Comment
doi: 10.1001/archderm.142.9.1233.
Topical calcineurin inhibitors labeling: putting the "box" in perspective
- PMID: 16983018
- DOI: 10.1001/archderm.142.9.1233
Item in Clipboard
Comment
Topical calcineurin inhibitors labeling: putting the "box" in perspective
Arch Dermatol.
2006 Sep.
No abstract available
Comment in
-
Topical calcineurin inhibitors revisited.Arch Dermatol. 2007 Apr;143(4):545-6. doi: 10.1001/archderm.143.4.545. Arch Dermatol. 2007. PMID: 17438195 No abstract available.
-
National Eczema Association and topical calcineurin inhibitor labeling.Arch Dermatol. 2007 Apr;143(4):546. doi: 10.1001/archderm.143.4.546-a. Arch Dermatol. 2007. PMID: 17438197 No abstract available.
Comment on
-
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks.Arch Dermatol. 2006 May;142(5):633-7. doi: 10.1001/archderm.142.5.633. Arch Dermatol. 2006. PMID: 16702502 No abstract available.
Similar articles
-
Topical calcineurin inhibitors revisited.Arch Dermatol. 2007 Apr;143(4):545-6. doi: 10.1001/archderm.143.4.545. Arch Dermatol. 2007. PMID: 17438195 No abstract available.
-
The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.J Am Acad Dermatol. 2006 May;54(5):818-23. doi: 10.1016/j.jaad.2006.01.054. J Am Acad Dermatol. 2006. PMID: 16635663 Review. No abstract available.
-
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks.Arch Dermatol. 2006 May;142(5):633-7. doi: 10.1001/archderm.142.5.633. Arch Dermatol. 2006. PMID: 16702502 No abstract available.
-
[Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ].MMW Fortschr Med. 2003 Jul 24;145(29-30):62. MMW Fortschr Med. 2003. PMID: 12958787 German. No abstract available.
-
Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.Clin Dermatol. 2010 Jan-Feb;28(1):52-6. doi: 10.1016/j.clindermatol.2009.04.001. Clin Dermatol. 2010. PMID: 20082951 Review.
Cited by
-
An Appropriate Response to the Black-Box Warning: Corrective, Barrier Repair Therapy in Atopic Dermatitis.Clin Med Dermatol. 2009 Feb 9;2:1-3. Clin Med Dermatol. 2009. PMID: 19779592 Free PMC article.
-
Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.Dermatol Reports. 2010 Sep 14;2(2):e13. doi: 10.4081/dr.2010.e13. eCollection 2010 Aug 31. Dermatol Reports. 2010. PMID: 25386250 Free PMC article. Review.
-
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.Clin Rev Allergy Immunol. 2011 Dec;41(3):282-95. doi: 10.1007/s12016-010-8231-1. Clin Rev Allergy Immunol. 2011. PMID: 21174234 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
